CADPS Antikörper (C-Term)

Produktnummer ABIN6990890

Produktdetails anti-CADPS Antikörper

Target: CADPS (Ca++-Dependent Secretion Activator (CADPS))

Bindungsspezifität: C-Term

Reaktivität: Human, Maus, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser CADPS Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (IF)

Spezifität: Numerous isoforms of CAPS1 are known to exist, the lower molecular weight bands seen in the immunoblot image are likely to be these isoforms. This CAPS1 antibody is predicted to be specific to CAPS1 and not recognize CAPS2.

Aufreinigung: CAPS1 Antibody is affinity chromatography purified via peptide column.

Immunogen: CAPS1 antibody was raised against a 20 amino acid synthetic peptide near the carboxy terminus of the human CAPS1. The immunogen is located within the last 50 amino acids of CAPS1.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: CAPS1 antibody can be used for detection of CAPS1 by Western blot at 0.5 - 1 μ,g/mL. Antibody can also be used for immunohistochemistry starting at 5 μ,g/mL. For immunofluorescence start at 20 μ,g/mL.

Antibody validated: Western Blot in rat samples, Immunohistochemistry in human samples and Immunofluorescence in human samples. All other applications and species not yet tested.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: CAPS1 Antibody is supplied in PBS containing 0.02 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,4 °C

Informationen zur Lagerung: CAPS1 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Details zu CADPS

Target: CADPS (Ca++-Dependent Secretion Activator (CADPS))

Andere Bezeichnung: CAPS1 (CADPS Produkte)

Synonyme: CADPS1 antikoerper, CAPS antikoerper, CAPS1 antikoerper, Caps antikoerper, Caps1 antikoerper, Caps2 antikoerper, AU067781 antikoerper, mKIAA1121 antikoerper, CADPS antikoerper, cadps antikoerper, MGC122552 antikoerper, CAPS-1 antikoerper, caps antikoerper, caps1 antikoerper, si:busm1-1i3.1 antikoerper, si:busm1-6a2.7 antikoerper, si:dz6a2.7 antikoerper, calcium dependent secretion activator antikoerper, Ca2+-dependent secretion activator antikoerper, Ca2+-dependent activator protein for secretion b antikoerper, Ca2+ dependent secretion activator antikoerper, Ca2+ dependent secretion activator L homeolog antikoerper, Ca2+-dependent activator protein for secretion a antikoerper, CADPS antikoerper, Cadps antikoerper, cadpsb antikoerper, cadps antikoerper, cadps.L antikoerper, cadpsa antikoerper

Hintergrund: CAPS1 Antibody: CAPS1 and its related protein CAPS2 encode novel neural/endocrine-specific cytosolic and peripheral membrane proteins. Both are essential components of the synaptic vesicle priming machinery and are required for the Ca2+-regulated exocytosis of secretory vesicles, CAPS-deficienct neurons contain no or very few fusion competent synaptic vesicles, causing a selective impairment of fast phasic transmitter release. CAPS1 acts at a stage in exocytosis that follows ATP-dependent priming, which involves the essential synthesis of phosphatidylinositol 4, 5-bisphosphate and is thought to be a specific regulator of large dense-core vesicle fusion.

Gen-ID: 8618

NCBI Accession: NP_899631

UniProt: Q9ULU8

Pathways: Synaptic Vesicle Exocytosis